Temporal changes in immune cell composition and cytokines in response to chemoradiation in rectal cancer.

about

Temporal changes in immune cell composition and cytokines in response to chemoradiation in rectal cancer.

Item

http://www.wikidata.org/entity/Q54958909

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Temporal changes in immune cel ...... emoradiation in rectal cancer.

@en

Temporal changes in immune cel ...... emoradiation in rectal cancer.

@nl

type

Item

label

Temporal changes in immune cel ...... emoradiation in rectal cancer.

@en

Temporal changes in immune cel ...... emoradiation in rectal cancer.

@nl

prefLabel

Temporal changes in immune cel ...... emoradiation in rectal cancer.

@en

Temporal changes in immune cel ...... emoradiation in rectal cancer.

@nl

P1476

Temporal changes in immune cel ...... hemoradiation in rectal cancer

@en

P2093

Kang Young Lee

http://www.w3.org/2001/XMLSchema#string

Min Soo Cho

http://www.w3.org/2001/XMLSchema#string

Sat Byol Lee

http://www.w3.org/2001/XMLSchema#string

Suk Kyung Beak

http://www.w3.org/2001/XMLSchema#string

Yong Joon Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Laboratory blood data have a significant impact on tumor response and outcome in preoperative chemoradiotherapy for advanced rectal cancer.

Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer.

New insights into IL-12-mediated tumor suppression.

Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer

Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation

Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy.

The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications.

Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients.

Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response.

P304

7565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-25970-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29765096

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5953940

http://www.w3.org/2001/XMLSchema#string